The Federal Circuit issued an opinion on Monday in GlaxoSmithKline LLC v. Banner Pharmacaps, Inc. illustrating how difficult it can be to overturn a district court determination based on a question of fact, at least when the question involves a...
By: McDonnell Boehnen Hulbert & Berghoff LLP
By: McDonnell Boehnen Hulbert & Berghoff LLP